期刊
GENES & DEVELOPMENT
卷 34, 期 7-8, 页码 544-559出版社
COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/gad.330746.119
关键词
nuclear receptor; oxidative stress; glutamine; glutathione; breast cancer; chemotherapy; gene signature; metabolic flux; organoid; mitochondria; taxane
资金
- Terry Fox Research Institute Program Project Team Grant on Oncometabolism
- Foundation Grants from the Canadian Institutes of Health Research (CIHR)
- CIHR [MOP106603]
- Vanier Canada Graduate Scholarship-CIHR
Excessive reactive oxygen species (ROS) can cause oxidative stress and consequently cell injury contributing to a wide range of diseases. Addressing the critical gaps in our understanding of the adaptive molecular events downstream ROS provocation holds promise for the identification of druggable metabolic vulnerabilities. Here, we unveil a direct molecular link between the activity of two estrogen-related receptor (ERR) isoforms and the control of glutamine utilization and glutathione antioxidant production. ERR alpha down-regulation restricts glutamine entry into the TCA cycle, while ERR gamma up-regulation promotes glutamine-driven glutathione production. Notably, we identify increased ERR gamma expression/activation as a hallmark of oxidative stress triggered by mitochondrial disruption or chemotherapy. Enhanced tumor antioxidant capacity is an underlying feature of human breast cancer (BCa) patients that respond poorly to treatment. We demonstrate that pharmacological inhibition of ERR gamma with the selective inverse agonist GSK5182 increases antitumor efficacy of the chemotherapeutic paclitaxel on poor outcome BCa tumor organoids. Our findings thus underscore the ERRs as novel redox sensors and effectors of a ROS defense program and highlight the potential therapeutic advantage of exploiting ERR gamma inhibitors for the treatment of BCa and other diseases where oxidative stress plays a central role.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据